Program Summary Division of Surveillance and Disease Control
Tuberculosis Control Program
Carmen M. Priddy, Program Manager
Purpose/Mission: The mission of the Tuberculosis Control Program is to achieve the absence of indigenous transmission of tuberculosis infection in West Virginia, which results in clinically apparent tuberculosis disease, by the year 2010 (incidence rate of 1/100,000 population).
What we do:
- Investigations of cases and contacts
- Surveillance
- Data collection/reporting
- Case management
- Drug Susceptibility testing
- TB treatment of both active and Latent TB Infection
- TB treatment monitoring
- TB screening
- Availability of clinical TB services
- Dissemination of information
Products / Services:
- Provide xrays for evaluation of active disease (32 patients) and Latent TB Infection (80+).
- Provide clinicians to evaluate active disease and Latent TB Infection.
- Provide support for surveillance/case investigation of TB to county health departments and other health care providers.
- Provide information on TB to health care providers and the general public.
- Provide testing materials and medications for TB cases and positive reactors.
- Provide reports on surveillance of TB to Centers for Disease Control and Prevention.
- Secure and allocate federal funds to ten county health departments for enhanced TB activities.
Customers:
- General Public
- County Health Departments
- Public and Private Health Care Providers - hospitals, private practitioners, laboratories, correctional facilities, migrant associations
- Educational Systems
- HIV/AIDS Programs
- Centers for Disease Control and Prevention
Tuberculosis Control Program
Program Summary - Goals & Measures Division of Surveillance and Disease Control Carmen M. Priddy, Program Manager
Goals
- At least 90% of initially infectious newly diagnosed cases of pulmonary tuberculosis will become noninfectious (i.e., convert their sputum from positive to negative culture) within 3 months of starting drug treatment.
- At least 90% of newly diagnosed cases of tuberculosis will complete an American Thoracic Society/Centers for Disease Control (ATC/CDC) recommended regimen of anti-TB drug therapy.
- At least 95% of close contacts to infectious TB cases will receive examinations, with at least 95% of infected contacts under 15 years of age and 75% of infected contacts 15 years of age and over placed on preventive therapy.
- At least 90% of infected contacts under the age of 15 placed on preventive therapy will complete a minimum of 6 continuous months of preventive therapy. At least 75% of infected contacts 15 years of age and older placed on preventive therapy will complete a minimum of 6 continuous months of preventive therapy.
- At least 95% of persons (non-contacts) with a positive tuberculin skin test identified through screening activities will be clinically evaluated for TB within 2 weeks of the skin test reading.
Program Contact Information:
Tuberculosis Control Program
350 Capitol Street, Room 125
Charleston, WV 25301
(304) 558-3669
Fax (304) 558-1825
In WV (800) 330-8126
Carmen M. Priddy, RN, BSN
Program Manager
carmenpriddy@wvdhhr.org
Carolyn Winkler, RN
Surveillance Nurse
carolynwinkler@wvdhhr.org
Barbara Simpkins
Program Secretary
barbarasimpkins@wvdhhr.org
Linda Fox
Program Office Assistant
lindafox@wvdhhr.org
Joyce Duncan
X-Ray Tech.
joyceduncan@wvdhhr.org
David Frush
X-Ray Tech.
davidfrush@wvdhhr.org
|
